Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Juin

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Cell Death & Disease|June 13, 2014
Bcl-xL controls a switch between cell death modes during mitotic arrestN Bah, L Maillet, J Ryan, et al.
Genesis (New York, N.Y. : 2000)|November 10, 2023
EMT and primary ciliogenesis: For better or worse in sickness and in healthCamille E Tessier, Aurore M M Dupuy, Thomas Pelé, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 29, 1998
Treatment of carcinoma of the uterine cervix with concomitant cisplatin, 5-fluorouracil and split course hyperfractionated radiotherapyN Tubiana-Mathieu, P Bonnier, F Delaby, et al.
The Journal of Biological Chemistry|November 13, 1998
The isolated complex of the translocase of the outer membrane of mitochondria. Characterization of the cation-selective and voltage-gated preprotein-conducting poreK P Künkele, P Juin, C Pompa, et al.
Cancer Gene Therapy|January 24, 2009
P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximabS Bouali, A-S Chrétien, C Ramacci, et al.
Oncogene|May 2, 2007
Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53C Chipoy, B Brounais, V Trichet, et al.
Cell Death & Disease|September 14, 2022
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive propertiesThomas L Bonneaud, Chloé C Lefebvre, Lisa Nocquet, et al.
Breast Cancer (Tokyo, Japan)|May 22, 2024
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtypePascal Jézéquel, Hamza Lasla, Wilfried Gouraud, et al.
Cell Death & Disease|February 10, 2017
Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xLJ Le Pen, L Maillet, K Sarosiek, et al.
Cell Death and Differentiation|November 11, 2006
TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein BaxG Bellot, P-F Cartron, E Er, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cell Death & Disease|June 13, 2014
Bcl-xL controls a switch between cell death modes during mitotic arrestN Bah, L Maillet, J Ryan, et al.
Genesis (New York, N.Y. : 2000)|November 10, 2023
EMT and primary ciliogenesis: For better or worse in sickness and in healthCamille E Tessier, Aurore M M Dupuy, Thomas Pelé, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 29, 1998
Treatment of carcinoma of the uterine cervix with concomitant cisplatin, 5-fluorouracil and split course hyperfractionated radiotherapyN Tubiana-Mathieu, P Bonnier, F Delaby, et al.
The Journal of Biological Chemistry|November 13, 1998
The isolated complex of the translocase of the outer membrane of mitochondria. Characterization of the cation-selective and voltage-gated preprotein-conducting poreK P Künkele, P Juin, C Pompa, et al.
Cancer Gene Therapy|January 24, 2009
P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximabS Bouali, A-S Chrétien, C Ramacci, et al.
Oncogene|May 2, 2007
Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53C Chipoy, B Brounais, V Trichet, et al.
Cell Death & Disease|September 14, 2022
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive propertiesThomas L Bonneaud, Chloé C Lefebvre, Lisa Nocquet, et al.
Breast Cancer (Tokyo, Japan)|May 22, 2024
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtypePascal Jézéquel, Hamza Lasla, Wilfried Gouraud, et al.
Cell Death & Disease|February 10, 2017
Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xLJ Le Pen, L Maillet, K Sarosiek, et al.
Cell Death and Differentiation|November 11, 2006
TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein BaxG Bellot, P-F Cartron, E Er, et al.
Pageof 7